PARLIAMENTARY WRITTEN QUESTION
Pancreatic Cancer (28 October 2014)
Question Asked
To ask the Secretary of State for Health, if he will make an assessment of the effect of the National Institute for Health and Care Excellence's health technology appraisals on pancreatic cancer research.
Asked by:
Sir Nicholas Dakin (Labour)
Asked by:
Sir Nicholas Dakin (Labour)
Answer
We have made no such assessment.
The National Institute for Health Research is investing £6.5 million over five years to 2017 in the Liverpool Pancreas Biomedical Research Unit. This unit is working in partnership with industry and leading research institutions to develop new treatments and diagnostic strategies for pancreatic cancer, so advancements in science can lead to benefits for patients.
Answered by:
George Freeman (Conservative)
3 November 2014
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.